FIELD: organic chemistry.
SUBSTANCE: invention relates to specific imidazo[1,2-a]pyridine derivatives. Invention also relates to use of said specific compounds for treating bacterial infection, pharmaceutical composition based on said specific compounds and a method of treating bacterial infection.
EFFECT: obtaining novel imidazo[1,2-a]pyridine derivatives, having high activity and useful in treating bacterial infections, including tuberculosis.
6 cl, 2 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVE BASED ON DIHYDROPYRIMIDO-RING AS HBV INHIBITOR | 2015 |
|
RU2693897C2 |
PIPERIDINE DERIVATIVES AS GPR119 AGONISTS | 2013 |
|
RU2603346C2 |
BENZO-DERIVATIVES WITH SIX-MEMBERED RING AS DPP-4 INHIBITOR AND USE THEREOF | 2015 |
|
RU2702644C2 |
MOLECULES WITH A PESTICIDAL FUNCTION AND INTERMEDIATE COMPOUNDS, COMPOSITIONS AND METHODS ASSOCIATED THEREWITH | 2016 |
|
RU2735602C2 |
ANTIINFECTIVE COMPOUNDS | 2011 |
|
RU2576662C2 |
CYCLOALKENYLARYLIC DERIVATIVES FOR INHIBITING TRANSPORT PROTEIN CHOLESTERIN ESTERS | 2012 |
|
RU2597266C2 |
NEW COMPOUNDS FOR TREATING AMYLOID OR AMYLOID-LIKE PROTEIN ASSOCIATED DISEASES | 2007 |
|
RU2469026C2 |
NEW PYRROLOPYRIMIDINE COMPOUND OR ITS SALT, PHARMACEUTICAL COMPOSITION CONTAINING IT, IN PARTICULAR, AGENT FOR PREVENTION AND / OR TREATMENT OF TUMORS AND SO ON, BASED ON INHIBITING INFLUENCE ON NAE | 2015 |
|
RU2658008C2 |
ANTITUMOUR EFFECT ENHANCER CONTAINING PYRROLOPYRIMIDINE COMPOUND | 2016 |
|
RU2710380C1 |
PD-L1 ANTAGONIST COMPOUND | 2020 |
|
RU2823231C1 |
Authors
Dates
2020-10-23—Published
2014-08-01—Filed